MX9710172A - Derivados de hidroxilamina anti-isquemicos y composiciones farmaceuticas. - Google Patents

Derivados de hidroxilamina anti-isquemicos y composiciones farmaceuticas.

Info

Publication number
MX9710172A
MX9710172A MX9710172A MX9710172A MX9710172A MX 9710172 A MX9710172 A MX 9710172A MX 9710172 A MX9710172 A MX 9710172A MX 9710172 A MX9710172 A MX 9710172A MX 9710172 A MX9710172 A MX 9710172A
Authority
MX
Mexico
Prior art keywords
formula
alkyl
group
hydroxylamine derivatives
pharmaceutical compositions
Prior art date
Application number
MX9710172A
Other languages
English (en)
Other versions
MXPA97010172A (es
Inventor
Laszlo Urogdi
Ede Marvanyos
Mihaly Barabas
Laszlo Jaszlits
Katalin Biro
Andrea Jednakovits
Erzsebet Radvanyne Hegedus
Maria Kurthy
Istvanne Udvardy Nagy
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of MX9710172A publication Critical patent/MX9710172A/es
Publication of MXPA97010172A publication Critical patent/MXPA97010172A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La invencion se refiere a derivados de hidroxilamina novedosos representados por la formula general (I), las sales ácidas de adicion farmacéuticamente aceptables de las mismas así como las composiciones farmacéuticas que contienen las mismas como ingrediente activo. Otro objetivo de la invencion es la preparacion de los derivados de hidroxilamina y sales de los mismos. Los compuesto de acuerdo con la invencion tienen efecto antiisquémico. En la formula anterior, (I) X es O, -NH o un grupo de la formula -NR'-, en donde R y R', independientemente uno del otro , son alquilo, cicloalquilo, fenilalquilo; un grupo fenilo opcionalmente substituido con halo, haloalquilo, alquilo, alcoxi o nitro; o un heteroanillo que contiene N; Rü es H o alcanoilo; R² es H o hidroxi acilado opcionalmente con alcanoilo; y Rü es un grupo de la formula -N(R4)R5 en donde R4 y R5, independientemente uno del otro, puede ser H, alquilo o un grupo de la formula -C(O)-NH-R en donde R es como se definio antes, o R4 y R5, cuando se toma junto con el nitrogeno adyacente unido al mismo, de un hereroanillo de 5 a 7 miembro el cual puede contener un heteroátomo adicional seleccionado de nitrogeno, oxígeno y azufre y que se substituye opcionalmente con alquilo de fenilalquilo.
MXPA/A/1997/010172A 1995-06-15 1997-12-15 Derivados de hidroxilamina anti-isquemicos y composiciones farmaceuticas MXPA97010172A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP9501756 1995-06-15
HU9501756A HU218480B (hu) 1995-06-15 1995-06-15 Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények

Publications (2)

Publication Number Publication Date
MX9710172A true MX9710172A (es) 1998-07-31
MXPA97010172A MXPA97010172A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
AU6237696A (en) 1997-01-15
ES2174077T3 (es) 2002-11-01
EP0832079A1 (en) 1998-04-01
ZA964978B (en) 1997-02-24
DK0832079T3 (da) 2002-06-03
ATE215075T1 (de) 2002-04-15
AU703163B2 (en) 1999-03-18
KR100444780B1 (ko) 2004-11-26
CA2221689A1 (en) 1997-01-03
PT832079E (pt) 2002-07-31
SK171397A3 (en) 1998-06-03
SI0832079T1 (en) 2002-08-31
PL324197A1 (en) 1998-05-11
DE69620175D1 (de) 2002-05-02
YU49419B (sh) 2006-01-16
IL122141A0 (en) 1998-04-05
PL185592B1 (pl) 2003-06-30
HRP960279A2 (en) 1997-12-31
HU9501756D0 (en) 1995-08-28
BR9608929A (pt) 1999-06-15
JP4083800B2 (ja) 2008-04-30
YU36996A (sh) 1998-11-05
HU218480B (hu) 2000-09-28
KR19990022961A (ko) 1999-03-25
DE69620175T2 (de) 2002-08-22
IL122141A (en) 2003-07-06
CZ295547B6 (cs) 2005-08-17
IN185781B (es) 2001-04-28
EP0832079B1 (en) 2002-03-27
HUT74621A (en) 1997-01-28
WO1997000251A1 (en) 1997-01-03
CZ401597A3 (cs) 1998-04-15
SK282953B6 (sk) 2003-01-09
US6002002A (en) 1999-12-14
JPH11507662A (ja) 1999-07-06
CA2221689C (en) 2007-08-07
HRP960279B1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
YU65902A (sh) Farmaceutske smeše koje sadrže derivate 3-aminoazetidina, novi derivati i njihovo spravljanje
ATE128975T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente.
TW260667B (es)
MX9306831A (es) Nuevos compuestos heterociclicos.
MY141488A (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ES2055535T3 (es) Derivados de amina.
ES8801806A1 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
CA2221689A1 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
AU689808B2 (en) Dithiocarbonimide derivative, fungicidal/insecticidal/ acaricidal agent containing said derivative as active ingredient, intermediate for use in production of said derivative and process for producing said derivative from said intermediate
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
ATE56438T1 (de) 1-(cyclohexyl&gt;-3,4-di-(hydro&gt;isochinolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees